Atra stock forecast.

Microsoft Corp Revenue Forecast for 2023 - 2025 - 2030. In the last four years, Microsoft Corp's Revenue has grown by 57.55%, rising from $125.84B to $198.27B. For next year, analysts predict Revenue of $257.87B, which would mean an increase of 30.06%. Over the next seven years, experts predict that Microsoft Corp's Revenue will …SmartAssetPaid Partner. Find real-time T - AT&T Inc stock quotes, company profile, news and forecasts from CNN Business.15 brokers have issued 1-year price targets for Palantir Technologies' stock. Their PLTR share price targets range from $5.00 to $25.00. On average, they anticipate the company's stock price to reach $13.25 in the next year. This suggests that the stock has a possible downside of 34.6%.CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.

Atara Biotherapeutics Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 0.57. Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.481%. Pessimistic target level: 0.56. Optimistic target level: 0.58.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Fuelcell Energy share forecasts, stock quote and buy / sell signals below. According to present data Fuelcell Energy's FCEL shares and potentially its market environment have been in bearish cycle last 12 months (if exists).

ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period.

Oncology Pharma's stock was trading at $0.3386 at the beginning of the year. Since then, ONPH shares have decreased by 99.9% and is now trading at $0.0002. View the best growth stocks for 2023 here.The MannKind Corporation stock price gained 5.56% on the last trading day (Friday, 17th Nov 2023), rising from $3.60 to $3.80. During the last trading day the stock fluctuated 6.06% from a day low at $3.63 to a day high of $3.85. The price has been going up and down for this period, and there has been a -4.04% loss for the last 2 weeks.ATRA Stock 12 Months Forecast. $5.05. (890.20% Upside) Based on 8 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. The average price target is $5.05 with a high forecast of $13.00 and a low forecast of $1.00. The average price target represents a 890.20% change from the last price of $0.51.Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.

Atara Biotherapeutics, Inc. (Ticker: ATRA) closed the trading day on December 1, 2023, with a slight decline of 1.85%, ending the session at $0.65. The stock traded within a range of $0.57 to $0.65 on the same day, indicating a degree of volatility. ... the stock's technical outlook and negative profitability metrics pose considerable risks for ...

The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingDec 2022 , the consensus EPS* forecast has ...

See Atara Biotherapeutics, Inc. (ATRA) history of stock splits. Includes date and ratio.Nov 27, 2023 · A share price of Atara Biotherapeutics Inc [ATRA] is currently trading at $0.68, up 18.34%. An important factor to consider is whether the stock is rising or falling in short-term value. The ATRA shares have gain 40.87% over the last week, with a monthly amount drifted -48.72%, and not seem to be holding up well Mar 30, 2023 · Should You Buy or Sell Atara Biotherapeutics Stock? Get The Latest ATRA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. UNG Signals & Forecast. There are few to no technical positive signals at the moment. The United States Natural Gas Fund, LP ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term …3 analysts have issued twelve-month target prices for SoundHound AI's stock. Their SOUN share price targets range from $3.60 to $5.00. On average, they expect the company's stock price to reach $4.53 in the next twelve months. This suggests a possible upside of 96.7% from the stock's current price.Get the latest Atara Biotherapeutics Inc (ATRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Find real-time SAIC - Science Applications International Corp stock quotes, company profile, news and forecasts from CNN Business.The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility ...Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.16 equities research analysts have issued twelve-month price targets for SoFi Technologies' stock. Their SOFI share price targets range from $3.00 to $15.00. On average, they anticipate the company's share price to reach $8.78 in the next year. This suggests a possible upside of 12.1% from the stock's current price.Find real-time ATRA - Atara Biotherapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.A share price of Atara Biotherapeutics Inc [ATRA] is currently trading at $0.68, up 18.34%. An important factor to consider is whether the stock is rising or falling in short-term value. The ATRA shares have gain 40.87% over the last week, with a monthly amount drifted -48.72%, and not seem to be holding up well

ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period.

During the last day, the stock moved $0.1000 between high and low, or 1.40%. For the last week, the stock has had daily average volatility of 1.24% . Our recommended stop-loss: $6.83 (-5.75%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 19 days ago.)Atara Biotherapeutics, Inc. Common Stock (ATRA) Stock Price, Quote, News & History | Nasdaq MY QUOTES: ATRA Edit my quotes Atara Biotherapeutics, Inc. Common …Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ... Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ... Atara Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ATRA updated stock price target summary. Atara Biotherapeutics Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 0.57. Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.481%. Pessimistic target level: 0.56. Optimistic target level: 0.58.So, when comparing one stock to another in a different industry, it's best make relative comparisons to that stock's respective industry values. -6,390.31% -223.52%Atara Biotherapeutics (NasdaqGS:ATRA) Stock Forecast & Analyst Predictions - Simply Wall St View Valuation Atara Biotherapeutics Future Growth Future …

The average Bit Digital stock price prediction forecasts a potential upside of 55.04% from the current BTBT share price of $2.58. What is BTBT's forecast return on equity (ROE) for 2023-2024? (NASDAQ: BTBT) forecast ROE is N/A, which is considered weak.

$0.65. DRRX 5.13%. Outlook Therapeutics Inc. $0.47. OTLK 1.50%. Gamida Cell Ltd. $0.33. GMDA 6.45%. Atara Biotherapeutics Inc. $0.65. ATRA 1.85%. Aclaris ...

Atara Biotherapeutics stock forecast for Apr 2025. Estimated Average Forecasted Atara Biotherapeutics Price: 1.93. Positive monthly dynamics of the instrument is expected with 6.030% volatility is expected. Pessimistic forecast: 1.88. Optimistic: 2.00. Atara Biotherapeutics stock forecast for May 2025.This year’s forecast. As for the 2023 expectation, City analysts currently think AstraZeneca will reward investors with a payout of $3.06 per share. That would represent a third consecutive ...16 sept 2020 ... See if the stock goes on to build a promising consolidation that could kick off a new price move. Atara Biotherapeutics (ATRA).Nov 24, 2023 · THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl... 4 days ago - Business Wire Atara Biotherapeutics To Participate at the Stifel Healthcare Conference The MacroGenics stock price gained 1.49% on the last trading day (Friday, 24th Nov 2023), rising from $7.39 to $7.50. During the last trading day the stock fluctuated 4.46% from a day low at $7.35 to a day high of $7.68. The price has been going up and down for this period, and there has been a 14.5% gain for the last 2 weeks.GDX Signals & Forecast. Mostly positive signals in the chart today. The VanEck Vectors Gold Miners ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long …Oct 9, 2023 · Atara Biotherapeutics stock forecast for Apr 2025. Estimated Average Forecasted Atara Biotherapeutics Price: 1.93. Positive monthly dynamics of the instrument is expected with 6.030% volatility is expected. Pessimistic forecast: 1.88. Optimistic: 2.00. Atara Biotherapeutics stock forecast for May 2025. Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Find the latest dividend history for Atara Biotherapeutics, Inc. Common Stock (ATRA) at Nasdaq.com.2.46%. $74.52M. Immunogen Inc. 6.11%. $4.3B. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find real-time PLTR - Palantir Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.

22 nov 2023 ... Benchmark actually lowered its SEEL stock forecast price to $1 and has a Speculative Buy rating. ... Tags ATRA, ATRA stock, how to find penny ...Stock Price Forecast The 9 analysts offering 12-month price forecasts for Science Applications International Corp have a median target of 115.00, with a high estimate of 130.00 and a low estimate ... The ATRA stock price is -767.69% off its 52-week high price of $5.64 and 69.23% above the 52-week low of $0.20. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.67 million shares traded. The 3-month trading volume is 3.89 million shares. The consensus among analysts is that Atara Biotherapeutics Inc ...Instagram:https://instagram. buffalo small cap fundweat stockscompanies filed for bankruptcysavings account or roth ira 2.46%. $74.52M. Immunogen Inc. 6.11%. $4.3B. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Aug 8, 2023 · The percentage change in ATRA’s stock price is not provided. Looking ahead, ATRA’s next reporting date is scheduled for August 9, 2023. Analysts forecast an EPS (earnings per share) of -$0.66 for the current quarter. In the previous year, ATRA reported annual revenue of $63.6 million but incurred a net loss of -$228.3 million. best stock chat roomswhat is a 1964 kennedy half dollar worth today The current average ATRA price target, as estimated by these analysts, is $3.00. The predictions for the future ATRA stock price range from a low of $3.00 to a high of $3.00, highlighting the variability of market expectations for ATRA. 22 nov 2023 ... Benchmark actually lowered its SEEL stock forecast price to $1 and has a Speculative Buy rating. ... Tags ATRA, ATRA stock, how to find penny ... sandp closings 6.1%. 10% most volatile stocks in US Market. 15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: ATRA is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 29% a week. Volatility Over Time: ATRA's weekly volatility has increased from 18% to 29% over the past year.P.O. Box 505000. Louisville, KY 40233. T: (781) 575-2879. [email protected]. Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions, including multiple sclerosis, that can be rapidly delivered to patients within …